📣 We're thrilled to share that we made the first shipment of our RSV vaccine yesterday! A monumental moment for Moderna, this marks our evolution into a multi-product company, and is a testament to #TeamModerna's incredible dedication and unwavering commitment to patients.
Moderna
Biotechnology Research
Cambridge, Massachusetts 604,642 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX Leader | Critical Design Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
Associate Director, Pharmacovigilance Operations - Project Management (PgMP/PMP)
Updates
-
In every age group, even a mild #COVID19 infection may trigger a lasting set of problems – but for some people with certain risk factors — age, pregnancy, chronic conditions or a compromised immune system — an infection may bring serious illness. Here's what you need to know about vaccination against COVID-19 this fall: https://lnkd.in/ekS3KNHS
-
Respiratory syncytial virus, or RSV, is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections, causing between 6,000 to 10,000 deaths each year amongst adults 65 years and older in the United States. Learn more about RSV, how you can help prevent it's spread, and new recommendations for RSV vaccinations from the CDC’s Advisory Committee on Immunization Practices: https://lnkd.in/eghWfM5c
-
-
📢 This week we sponsored a Washington Post Live event focusing on the public health challenge of #LongCOVID. This crucial conversation brought together policymakers, medical researchers, and patients to explore the causes, prevalence, and long-term impacts of this condition. Thank you to Dr. Ziyad Al-Aly, Dr. Linda Sprague Martinez, Jaime Seltzer, Chimére L. Sweeney, Dr. Ashwin Vasan, and Rachel Beale for their invaluable contributions and commitment to understanding and combatting Long COVID. Together, we can make a difference!
-
Long COVID presents a growing public health challenge worldwide, and is having a major impact on the productivity of health systems and the wider workforce - with severe cases potentially costing the economy $200 billion in lost annual wages in the US alone. Join leading policymakers, medical researchers and patient advocates tomorrow at 9:00 am ET for a live conversation about the causes, prevalence and long-term impacts of #LongCOVID ⬇ https://lnkd.in/eiRcjSXN
The looming public health challenge of long covid
washingtonpost.com
-
A large new study in The New England Journal of Medicine shows that among people in the U.S. infected during the first two years of the pandemic, the percentage of vaccinated individuals who developed #LongCOVID was significantly lower than that of unvaccinated individuals. This study provides some of the strongest evidence yet that #vaccines reduce the risk of developing Long COVID. Learn more: https://lnkd.in/d25Pdp-2
Vaccines Significantly Reduce the Risk of Long Covid, Study Finds
https://www.nytimes.com
-
We announced today that David M. Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group, will join Moderna’s Board of Directors, effective August 5, 2024. Learn more: https://lnkd.in/e9hntUEu
-
-
Ever wondered why some vaccinated people still get sick? There could be a few different reasons why! 💉🤒 Watch the latest episode of #CoffeeBreakScience, featuring Guha Asthagiri Arunkumar, M.S., Ph.D., to find out! 🔎 ☕️
-
We are proud to have earned a top score on the Disability Equality Index and recognized as a #BestPlaceToWork24 for #DisabilityInclusion for the 3rd year in a row! 🏆 Our commitment to diversity and inclusion starts with belonging, which we see as essential for our people to thrive at Moderna. Thank you Disability:IN for the recognition, and for driving disability inclusion and accessible innovation for all.
Disability:IN proudly announces the 2024 Best Places to Work for #DisabilityInclusion. Congratulations to the Top Scoring Companies*! #AreYouIN? *Note: A score of 100 on the Disability Equality Index does not imply perfection. American Association of People with Disabilities (AAPD) and Disability:IN acknowledge that inclusion practices vary across companies and industries. A score of 100 indicates adherence to many leading disability inclusion practices.
2024 Best Places to Work: Announcing the Disability Equality Index® Top Scoring Companies
Disability:IN on LinkedIn
-
#mRNA technology has gained significant attention, particularly in the realm of vaccine development. But what exactly is mRNA, and why does it hold such potential in modern #medicine? Read our latest blog to learn more about the basics of mRNA, how it functions within our bodies, and its role in the development of vaccines: https://lnkd.in/em3bSR7a
-